Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

4.840 +0.250 (+5.45%)
Streaming Delayed Price Updated: 10:00 AM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,109
Open 4.320
Bid (Size) 4.840 (100)
Ask (Size) 4.900 (100)
Prev. Close 4.590
Today's Range 4.210 - 4.980
52wk Range 2.900 - 11.96
Shares Outstanding 752,755
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Reversal Alert: VTIX, MARA, IBRX, BATL, NDRA, EEIQ Gain Momentum as Multi-Sector Catalysts Build
Via AB Newswire
News headline image
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside
Via AB Newswire
Topics Artificial Intelligence

Performance

YTD
+12.8%
+12.8%
1 Month
+25.4%
+25.4%
3 Month
-4.7%
-4.7%
6 Month
-1.2%
-1.2%
1 Year
+15.8%
+15.8%

More News

Read More
News headline image
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now!
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
Via AB Newswire
News headline image
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA)
Via Get News
News headline image
NASDAQ March 2026: VTIX, ONDS, RUBI, NDRA, SOUN + Others – February’s Most Shorted Names Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
Stocks in the News: ALBT, NDRA, CURX, HCTI – AI, Clinical Milestones Drive Market Surges
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): A Dual-Engine Growth Story Alongside KNRX, BATL, TALK, DNN, VZLA in Focus
Via AB Newswire
News headline image
5 Stocks Under $5 to Watch Now: OBAI, NDRA, RIME, VTIX, OPEN
Via AB Newswire
Topics Artificial Intelligence Economy
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges See Why Now! FEED, SER, TRX, XHLD, BATL Inside
Via AB Newswire
Topics Derivatives
News headline image
$5 Stocks: NDRA, IBRX, MOVE, RVLY Drawing Attention Watch Now!
Via AB Newswire
News headline image
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRA – January 2026 Focus
Via AB Newswire
Topics Derivatives
News headline image
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active
Via AB Newswire
News headline image
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential
Via AB Newswire
Topics Artificial Intelligence Death
News headline image
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform
Via AB Newswire
News headline image
Datavault AI (NASDAQ: DVLT) Licenses Healthcare IP to Wellgistics Health (NASDAQ: WGRX); Bonus Stocks in the News This Week TOON, NDRA, PRSO, RDZN more inside
Via AB Newswire
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology
Via AB Newswire

Frequently Asked Questions

Is ENDRA Life Sciences Inc. - Common Stock publicly traded?
Yes, ENDRA Life Sciences Inc. - Common Stock is publicly traded.
What exchange does ENDRA Life Sciences Inc. - Common Stock trade on?
ENDRA Life Sciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ENDRA Life Sciences Inc. - Common Stock?
The ticker symbol for ENDRA Life Sciences Inc. - Common Stock is NDRA on the Nasdaq Stock Market
What is the current price of ENDRA Life Sciences Inc. - Common Stock?
The current price of ENDRA Life Sciences Inc. - Common Stock is 4.840
When was ENDRA Life Sciences Inc. - Common Stock last traded?
The last trade of ENDRA Life Sciences Inc. - Common Stock was at 03/27/26 10:00 AM ET
What is the market capitalization of ENDRA Life Sciences Inc. - Common Stock?
The market capitalization of ENDRA Life Sciences Inc. - Common Stock is 3.64M
How many shares of ENDRA Life Sciences Inc. - Common Stock are outstanding?
ENDRA Life Sciences Inc. - Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.